ELAN — Elanco Animal Health Inc

—
NYSE · Health Care · Pharmaceuticals · CIK 1739104 ·
Last close
$22.31
Market Cap
$11.14B
52W High
$27.98
52W Low
$18.93
ADV30
5,309,787
Next earnings
2026-11-06

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 1,368,000,000 798,000,000 118,000,000 54,000,000 13,561,000,000 530,000,000 6,973,000,000
Mar 2026 1,371,000,000 785,000,000 169,000,000 57,000,000 13,222,000,000 428,000,000 6,722,000,000
Dec 2025 1,144,000,000 589,000,000 19,000,000 -276,000,000 13,358,000,000 545,000,000 6,811,000,000
Sep 2025 1,137,000,000 607,000,000 27,000,000 -34,000,000 13,551,000,000 505,000,000 6,802,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$617,000,000
Investing CF
$-335,000,000
Financing CF
$-310,000,000
CapEx
$-238,000,000
Dividends Paid
—
Buybacks
$-49,000,000
EPS Diluted TTM
$-0.41
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-2,071,000,000
Inventory
$1,769,000,000
Receivables
$1,152,000,000
ST Investments
—
EBIT TTM
$82,000,000
Pretax Income TTM
$-166,000,000
Interest Exp TTM
$248,000,000
Analysts
14

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,020,000,256
EBITDA
$1,007,000,000
Free Cash Flow
$826,875,008
Enterprise Value
$15,279,238,144
Total Cash
$530,000,000
Total Debt
$4,232,999,936
Shares Out
499,449,583
Trailing EPS
$-0.41
Book Value
$13.19
ROE
-3.0%
ROA
1.6%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 4,715,000,000 252,000,000 -232,000,000 13,358,000,000 6,811,000,000 6,547,000,000 560,000,000
Dec 2024 4,439,000,000 251,000,000 338,000,000 12,614,000,000 6,518,000,000 6,096,000,000 541,000,000
Dec 2023 4,417,000,000 326,000,000 -1,231,000,000 14,362,000,000 8,139,000,000 6,223,000,000 271,000,000
Dec 2022 4,411,000,000 384,000,000 -78,000,000 15,491,000,000 8,202,000,000 7,289,000,000 452,000,000

TTM Snapshot

Revenues TTM
$4,317,000,000
NetIncome TTM
$-730,000,000
OpCashFlow TTM
$0
Assets (Latest)
$13,358,000,000
Forward EPS
$1.28

Max Pain — expiry 2026-10-16

max pain strike: $22.00 · spot: $22.42 · call oi: 4,371 · put oi: 1,292
Expected Move to 2026-10-16: ±$1.75 (7.81%) — implied range $20.67 – $24.17 · ATM straddle on $22.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
BMRN BIOMARIN PHARMACEUTICAL INC $11.66B $60.26 —
MDGL MADRIGAL PHARMACEUTICALS, INC. $11.93B $516.56 —
AXSM Axsome Therapeutics, Inc. $10.22B $195.09 —
RDY DR REDDYS LABORATORIES LTD $10.20B $12.25 —
SMMT Summit Therapeutics Inc. $12.45B $15.61 —

News headlines (Yahoo Finance, 1h cache)

Elanco Animal Health Eyes Growth, Deleveraging as Quattro and Zenrelia Gain Ground
2026-09-26 10:02 · Yahoo
Elanco to Participate in BofA Securities Global Healthcare Conference 2026
2026-09-17 11:57 · Yahoo
Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care
2026-09-15 16:05 · Yahoo
Is Elanco Animal Health (ELAN) Undervalued As Growth Expectations Meet A Recent Pullback?
2026-09-14 14:12 · Yahoo
Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement
2026-09-11 11:58 · Yahoo
Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
2026-09-10 11:58 · Yahoo
Elanco Director Purchases 40,000 Shares for $936,000
2026-09-04 20:45 · Yahoo
Elanco Scales Biologics Capabilities With Expansion of Kansas Manufacturing Facility
2026-08-31 13:30 · Yahoo
Elanco celebrates $120 million expansion of Elwood manufacturing facility
2026-08-27 03:59 · Yahoo
Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility
2026-08-26 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.